Completed
The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects
NCT03634436
Dyslipidemias, Hypercholesteremia
Beijing, Beijing Municipality, China
View Trial Details
Completed
NCT Number: NCT01477944
Pattern of Statins Use in Catalonia
To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
About this study
Pattern of statins use in Catalonia.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient with a new prescription of statin Patients receiving one or more changes of the statins treatment
Exclusion criteria
- Patient with not full information
Treatment and study plan
Primary outcomes
-
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.
Time frame: From 1st September 2009 to 30th August 2010
-
Type of prescriber
Time frame: From 1st September 2009 to 30th August 2010
Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.)
-
Date of change from previous statin to new.
Time frame: From 1st September 2009 to 30th August 2010
Secondary outcomes
-
Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy.
Time frame: From 1st September 2009 to 30th August 2010
-
Total cholesterol
Time frame: From 1st September 2009 to 30th August 2010
Total Cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin.
That values will be collected for all the patients fulfilling criteria.
-
Low Density Lipoprotein (LDL) cholesterol concentration
Time frame: From 1st September 2009 to 30th August 2010
LDL cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin.
-
High Density Lipoproteins (HDL) cholesterol concentration
Time frame: From 1st September 2009 to 30th August 2010
HDL data was collected till the last laboratory values before the date of change from previous statin to new statin.
-
Triglicerides (TG) concentration
Time frame: From 1st September 2009 to 30th August 2010
TG data was collected till the last laboratory values before the date of change from previous statin to new statin.
-
Aspartate Aminotransferase (ASAT) concentration
Time frame: From 1st September 2009 to 30th August 2010
ASAT data was collected till the last laboratory values before the date of change from previous statin to new statin.
-
Serum Glucose concentration
Time frame: From 1st September 2009 to 30th August 2010
Serum Glucose data was collected till the last laboratory values before the date of change from previous statin to new statin.
-
Serum Creatin Kinase (CK) concentration
Time frame: From 1st September 2009 to 30th August 2010
CK data was collected till the last laboratory values before the date of change from previous statin to new statin.
Sponsors and collaborators
Lead sponsor
AstraZeneca
Industry
Registry information
Important dates
- Study start
- 2012
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Nov 23, 2011
- Registry last updated
- Feb 22, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Completed
The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia
NCT05164185
Dyslipidemias, Endothelial Dysfunction
Stockholm, Sweden
View Trial Details
Completed
Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes
NCT02850224
Blood Pressure, Body Weight
Detroit, Michigan, United States
View Trial Details
Completed
Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
NCT02722408
Dyslipidemias, Hypercholesteremia
Beverly Hills, California, United States
View Trial Details